James Investment Research’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,575
Closed -$484K 478
2019
Q4
$484K Hold
9,575
0.03% 231
2019
Q3
$452K Buy
9,575
+5,000
+109% +$228K 0.03% 235
2019
Q2
$215K Sell
4,575
-9,435
-67% -$435K 0.02% 351
2019
Q1
$675K Sell
14,010
-8,590
-38% -$430K 0.04% 355
2018
Q4
$1.01M Buy
+22,600
New +$1.18M 0.06% 359
2018
Q2
Sell
-29,100
Closed -$1.82M 801
2018
Q1
$1.82M Buy
+29,100
New +$2M 0.07% 364
2014
Q1
Sell
-186
Closed -$12K 512
2013
Q4
$12K Buy
+186
New +$11.4K ﹤0.01% 477

Other funds holding CAH

James Investment Research's CAH Position: Q1 2020 in Review

James Investment Research sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 9,575 shares — an estimated $484K sold.

James Investment Research first reported a position in CAH in Q4 2013 and held it in 7 quarters. The position peaked at $1.82M in Q1 2018. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • James Investment Research reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • James Investment Research sold 9,575 Cardinal Health shares in Q1 2020, an estimated $484K.
  • James Investment Research first reported a position in Cardinal Health in Q4 2013 and held it in 7 quarters.
  • James Investment Research's Cardinal Health position peaked at $1.82M in Q1 2018.
  • 721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on James Investment Research's 13F filing for Q1 2020, filed 22 Apr 2020.